1. Olokoba A.B., Obateru O.A., Olokoba L.B.. Type 2 diabetes mellitus: a review of current trends. Oman Med J 27(4):2012 Jul;269-273.
2. Shikata K., Ninomiya T., Kiyohara Y.. Diabetes mellitus and cancer risk: review of the epidemiological evidence. Cancer Sci 104(1):2013 Jan;9-14.
3. Meshkani R., Saberi H., Mohammadtaghvaei N.. Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects. Mol Cell Biochem 359(1–2):2012 Jan;225-233.
4. Goldstein B.J.. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 90(5A):2002 Sep;3G-10G.
5. Hamman R.F.. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 8(4):1992 Dec;287-338.
6. Li H., Groop L., Nilsson A.. A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes. J Clin Endocrinol Metab 88(6):2003 Jun;2767-2774.
7. Nishimura M., Obayashi H., Mizuta I.. TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 64(2):2003 Feb;302-309.
8. Rasmussen S.K., Urhammer S.A., Jensen J.N.. The -238 and -308 G-->A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J Clin Endocrinol Metab 85(4):2000 Apr;1731-1734.
9. Feng R.N., Zhao C., Sun C.H.. Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus. PLoS One 6(4):2011 Apr;e18480.
10. Dalziel B., Gosby A.K., Richman R.M.. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 10(5):2002 May;401-407.
11. Day C.P., Grove J., Daly A.K.. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41(4):1998 Apr;430-434.
12. Fernandez-Real J.M., Gutierrez C., Ricart W.. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46(9):1997 Sep;1468-1472.
13. Heijmans B.T., Westendorp R.G., Droog S.. Association of the tumour necrosis factor alpha -308G/A polymorphism with the risk of diabetes in an elderly population-based cohort. Genes Immun 3(4):2002 Jun;225-228.
14. Romeo S., Sentinelli F., Capici F.. The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution. BMC Med Genet 2:2001 Sep;10.
15. Walston J., Seibert M., Yen C.J.. Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance. Diabetes 48(10):1999 Oct;2096-2098.
16. Feng R., Li Y., Zhao D.. Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis. Acta Diabetol 46(4):2009 Dec;339-343.
17. Santos M.J.L., Patiño G.A., Angel B.B.. Association between tumor necrosis factor-alpha promoter polymorphisms and type 2 diabetes and obesity in Chilean elderly women. Rev Med Chil 134(9):2006 Sep;1099-1106.
18. Zeggini E., Groves C.J., Parkinson J.R.. Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes. Diabetologia 48(10):2005 Oct;2013-2017.
19. Bouhaha R., Baroudi T., Ennafaa H.. Study of TNFalpha -308G/A and IL6 -174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population. Clin Biochem 43(6):2010 Apr;549-552.
20. Berhouma R., Kouidhi S., Ammar M.. Genetic susceptibility to type 2 diabetes: a global meta-analysis studying the genetic differences in Tunisian populations. Hum Biol 84(4):2012 Aug;423-435.
21. Kwon J.M., Goate A.M.. The candidate gene approach. Alcohol Res Health 24(3):2000;164-168.
22. Zhu M., Zhao S.. Candidate gene identification approach: progress and challenges. Int J Biol Sci 3(7):2007 Oct;420-427.
23. Furuta M., Yano Y., Ito K.. Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 56(2):2002 May;141-145.
24. Liu H.L., Lin Y.G., Wu J.. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes. Eur J Clin Pharmacol 64(7):2008 Jul;663-671.
25. Shiau M.Y., Wu C.Y., Huang C.N.. TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens 61(5):2003 May;393-397.
26. Elsaid A., Helaly M.A., Hatata E.Z.. TNF-α-308 and INF-γ+874 Gene polymorphisms in relation to susceptibility and severity of type 2 diabetes mellitus among Egyptian cases. Eur J Gen Med 9(3):2012;173-177.
27. Lee S.C., Pu Y.B., Thomas G.N.. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism 49(8):2000 Aug;1021-1024.
28. Hoffstedt J., Eriksson P., Hellstrom L.. Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia 43(1):2000 Jan;117-120.
29. Herrmann S.M., Ricard S., Nicaud V.. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 28(1):1998 Jan;59-66.
30. Brand E., Schorr U., Kunz I.. Tumor necrosis factor-alpha-308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 25(4):2001 Apr;581-585.
31. Hamann A., Mantzoros C., Vidal-Puig A.. Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211(3):1995 Jun;833-839.
32. Kubaszek A., Pihlajamaki J., Komarovski V.. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52(7):2003 Jul;1872-1876.
33. Haghani K., Bakhtiyari S.. The study on the relationship between IRS-1 Gly972Arg and IRS-2 Gly1057Asp polymorphisms and type 2 diabetes in the Kurdish ethnic group in West Iran. Genet Test Mol Biomarkers 16(11):2012 Nov;1270-1276.
34. Saberi H., Mohammadtaghvaei N., Gulkho S.. The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population. Mol Cell Biochem 350(1–2):2011 Apr;113-118.
35. Garcia-Elorriaga G., Mendoza-Aguilar M., del Rey-Pineda G.. Genetic polymorphisms of the tumor necrosis factor and lymphotoxin alpha in type 2 diabetes. Rev Med Inst Mex Seguro Soc 51(1):2013 Jan–Feb;42-49.